chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Incorrect route of product administration, Joint range of motion decreased, Pain in extremity, Physical examination
Clinical narrative: Several days after injection left arm and shoulder hurt. I could not lift any weight and had limited range of mobility. One week after vaccine I reported to my PCP who examined me and said I was fine. One week later I reported to my PCP again who again told me I was fine. Two weeks later after arm and shoulder did not improve I saw another doctor who agreed the injection was too high and too deep and sent me to physical therapy. The pharmacy tech injected too high on my arm and went very deep inside. I have been in physical therapy for 5 weeks and there has been improvement with range and weight being put on joint. Physical therapist is unsure if physical therapy will fix it. New doctor is checking on steroid injections to ease pain.  The pain one week after injection was a 8/10. Now it rates 5/10.  It seems to be getting better but I still can't use my arm and shoulder like I could before the vaccine.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Extra dose administered
Clinical narrative: Patient had received the primary series for Moderna. She came to the clinic today to receive the Moderna booster. Vaccine was given by pharmacy technician  and given out of the bottle that had expired prior to vaccination. Patient was informed and the Moderna booster was given from a newly opened vaccine vial. Patient stayed in the clinic after vaccination for a few minutes and then left.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Mobility decreased, Muscle spasms, Pain, Paraesthesia
Clinical narrative: Lower back pain started 2 days (1/12) after booster shot. 8/10 on pain scale. Limited mobility, agonizing pain when sneezing. Sharp pain when laughing. Not being able to bend down due to excruciating pain.  Pain persisted and now today (1/19) it has radiated down to my tailbone and I feel tingles down my  thighs and feet. Pain level is 5/10. I went to urgent care and they said I have back spasms and sciatic pain.  I have no pre-existing spinal issues or injuries. I am a healthy /fit young person.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Sciatica, Sneezing
Clinical narrative: Lower back pain started 2 days (1/12) after booster shot. 8/10 on pain scale. Limited mobility, agonizing pain when sneezing. Sharp pain when laughing. Not being able to bend down due to excruciating pain.  Pain persisted and now today (1/19) it has radiated down to my tailbone and I feel tingles down my  thighs and feet. Pain level is 5/10. I went to urgent care and they said I have back spasms and sciatic pain.  I have no pre-existing spinal issues or injuries. I am a healthy /fit young person.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Bone pain, Headache, Influenza, Pain, Pallor
Clinical narrative: Started out like an extreme case of flu. I was very pale, ached all over, had a headache that wouldn't quit and every bone in my body hurt. When I talked to the doctor, she looked at me and said that it was a perfect case of the reaction to the vaccine and this lasted for about 36 hours. After about 36 hours, I felt as good as new.
Age: 11.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Feeling hot, Flushing, Tachycardia
Clinical narrative: Patient reported feeling flushed, hot, and short of breath minutes post-vaccination. Patient was escorted to nurse clinic where he was evaluated by MD. Tachy with HR 113 and BP 131/83 (94), Temp 98.2. Vitals stabilized and patient reported feeling better and was discharged.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Hyperaesthesia, Insomnia, Pruritus, Urticaria
Clinical narrative: 9 days after receiving the booster, I started having severe itching and hives which come and go.  These were manageable during the day, but kept me up at night.  These continued for about a month with no specific cause identified, but I did suspect the Moderna vaccine.  A week after my first dose I did have hives in my trunk and upper extremities - not  itchy and they lasted about 4-5 days.  After my second shot, I had a hot angry spot - Covid Arm for a few days - hardly noticeable.  After the third shot the symptoms were very hard to live with.  Extreme skin itchiness and sensitivity, which caused the inability to sleep through the night.  Benadryl, Claritin and Zyrtec have all helped some and anti-itch cream has also helped, but not resolved the symptoms.  I am currently on a seven day regimen of prednisone - 40 mg for 5 days, 20 mg for 2 days combined with Zyrtec.  My symptoms have completely vanished.  I am unsure if they will recur when my prednisone is done.
Age: 55.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Hospitalized, COVID (+) sxs, not known, POA did not return Agency attempt to call
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Magnetic resonance imaging joint, Periarthritis, Ultrasound scan normal
Clinical narrative: adhesive capsulitis - left shoulder
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Blepharospasm, Headache, Malaise
Clinical narrative: The next day after vaccine had a very bad pounding headache, which made her right eye start to twitch. She became very ill.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Chest X-ray, Chest pain, Dyspnoea, Electrocardiogram
Clinical narrative: Suffured chest pain, arm pain, and shortness of breath. Less then 24 hours after booster dose. Went to emergency room. Had ekg, xray, and blood work. Then saw my primary doctor.. I was diagnosed with Pericarditis. It is still an on going condition which has not resolved.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pericarditis
Clinical narrative: Suffured chest pain, arm pain, and shortness of breath. Less then 24 hours after booster dose. Went to emergency room. Had ekg, xray, and blood work. Then saw my primary doctor.. I was diagnosed with Pericarditis. It is still an on going condition which has not resolved.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Acute kidney injury, Alanine aminotransferase normal, Aspartate aminotransferase increased, Blood alkaline phosphatase normal, Blood bilirubin normal
Clinical narrative: 81 Y female with hx of HTN, HLD, MDD, pulmonary HTN, bedbound status due to severe obesity and hip/knee arthritis, recent hospitalization 12/3-12/15/21 for acute cholecystitis s/p cholecystostomy on 12/4/21 c/b bacteremia, buttock wounds and R leg cellulitis, COVID-19 positive on 12/25/21, who presented with nausea and malaise. Remained non-hypoxic, received remesivir x3 days to prevent severe disease per ID recs. Was noted to be neutropenic fever likely due to COVID. Labs not suggestive of DIC. HIT labs pending, SQ heparin held. Urine cx grew enterococcus cloacae and VRE but was asymptomatic, likely colonized urine. Patient and family opted to bring patient home with home health PT, declined SNF. Patient safe to be off isolation now per current guidelines.  #CORONAVIRUS COVID-19 DISEASE Received first dose Moderna vaccine on 12/14/21. Symptom onset on ~12/17/21, COVID positive on 12/25/21. Last known fever on 12/29/21. Except for cough and malaise, no respiratory symptoms, satting well on room air. No oxygen requirement. CRP mildly elevated. Risk factors: obesity. Patient remained nonhypoxic. Was treated with remdesivir for 3 days (12/29-12/31) given she has risk factor (obesity) and for prevention to severe disease per ID recommendations    #NEUTROPENIC FEVER #LEUKOPENIA  #THROMBOCYTOPENIA, UNSPECIFIED  Neutropenia secondary to COVID. DIC labs negative. Patient was on SQ heparin at SNF and last hospitalization. 4T score for HIT is 2 points: low probability for HIT. Noted to have neutropenic fever on 12/31. Source of fever likely COVID. Blood cultures no growth. Dc'ed abx given likely from COVID. Cell lines stable. -repeat cbc in 1 week -f/u HIT serologies -hold SQH   #UTI asymptomatic and ucx growing enterococcus cloacae and VRE -asymptomatic and not septic, likely colonized, hold off on tx   #NAUSEA  #CONSTIPATION  Patient has baseline nausea even during prior hospitalization. Likely worsened by COVID infection. Ct showed no obstruction and no evidence of cholecystitis or other acute abnormalities. No abdominal pain or peritoneal signs. -f/u general surgery for chole drain   #NONTRAUMATIC ACUTE KIDNEY INJURY  Cr 1.37 from baseline ~1, likely from dehydration. Resolved after fluids. -daily chem7 Reason for Hospital Admission (Admitting Diagnosis):  COVID-19 disease, AKI
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Blood chloride decreased, Blood cholesterol normal, Blood creatinine increased, Blood culture negative, Blood lactic acid
Clinical narrative: 81 Y female with hx of HTN, HLD, MDD, pulmonary HTN, bedbound status due to severe obesity and hip/knee arthritis, recent hospitalization 12/3-12/15/21 for acute cholecystitis s/p cholecystostomy on 12/4/21 c/b bacteremia, buttock wounds and R leg cellulitis, COVID-19 positive on 12/25/21, who presented with nausea and malaise. Remained non-hypoxic, received remesivir x3 days to prevent severe disease per ID recs. Was noted to be neutropenic fever likely due to COVID. Labs not suggestive of DIC. HIT labs pending, SQ heparin held. Urine cx grew enterococcus cloacae and VRE but was asymptomatic, likely colonized urine. Patient and family opted to bring patient home with home health PT, declined SNF. Patient safe to be off isolation now per current guidelines.  #CORONAVIRUS COVID-19 DISEASE Received first dose Moderna vaccine on 12/14/21. Symptom onset on ~12/17/21, COVID positive on 12/25/21. Last known fever on 12/29/21. Except for cough and malaise, no respiratory symptoms, satting well on room air. No oxygen requirement. CRP mildly elevated. Risk factors: obesity. Patient remained nonhypoxic. Was treated with remdesivir for 3 days (12/29-12/31) given she has risk factor (obesity) and for prevention to severe disease per ID recommendations    #NEUTROPENIC FEVER #LEUKOPENIA  #THROMBOCYTOPENIA, UNSPECIFIED  Neutropenia secondary to COVID. DIC labs negative. Patient was on SQ heparin at SNF and last hospitalization. 4T score for HIT is 2 points: low probability for HIT. Noted to have neutropenic fever on 12/31. Source of fever likely COVID. Blood cultures no growth. Dc'ed abx given likely from COVID. Cell lines stable. -repeat cbc in 1 week -f/u HIT serologies -hold SQH   #UTI asymptomatic and ucx growing enterococcus cloacae and VRE -asymptomatic and not septic, likely colonized, hold off on tx   #NAUSEA  #CONSTIPATION  Patient has baseline nausea even during prior hospitalization. Likely worsened by COVID infection. Ct showed no obstruction and no evidence of cholecystitis or other acute abnormalities. No abdominal pain or peritoneal signs. -f/u general surgery for chole drain   #NONTRAUMATIC ACUTE KIDNEY INJURY  Cr 1.37 from baseline ~1, likely from dehydration. Resolved after fluids. -daily chem7 Reason for Hospital Admission (Admitting Diagnosis):  COVID-19 disease, AKI
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Blood potassium normal, Blood sodium normal, Blood triglycerides increased, Blood urea increased, C-reactive protein increased
Clinical narrative: 81 Y female with hx of HTN, HLD, MDD, pulmonary HTN, bedbound status due to severe obesity and hip/knee arthritis, recent hospitalization 12/3-12/15/21 for acute cholecystitis s/p cholecystostomy on 12/4/21 c/b bacteremia, buttock wounds and R leg cellulitis, COVID-19 positive on 12/25/21, who presented with nausea and malaise. Remained non-hypoxic, received remesivir x3 days to prevent severe disease per ID recs. Was noted to be neutropenic fever likely due to COVID. Labs not suggestive of DIC. HIT labs pending, SQ heparin held. Urine cx grew enterococcus cloacae and VRE but was asymptomatic, likely colonized urine. Patient and family opted to bring patient home with home health PT, declined SNF. Patient safe to be off isolation now per current guidelines.  #CORONAVIRUS COVID-19 DISEASE Received first dose Moderna vaccine on 12/14/21. Symptom onset on ~12/17/21, COVID positive on 12/25/21. Last known fever on 12/29/21. Except for cough and malaise, no respiratory symptoms, satting well on room air. No oxygen requirement. CRP mildly elevated. Risk factors: obesity. Patient remained nonhypoxic. Was treated with remdesivir for 3 days (12/29-12/31) given she has risk factor (obesity) and for prevention to severe disease per ID recommendations    #NEUTROPENIC FEVER #LEUKOPENIA  #THROMBOCYTOPENIA, UNSPECIFIED  Neutropenia secondary to COVID. DIC labs negative. Patient was on SQ heparin at SNF and last hospitalization. 4T score for HIT is 2 points: low probability for HIT. Noted to have neutropenic fever on 12/31. Source of fever likely COVID. Blood cultures no growth. Dc'ed abx given likely from COVID. Cell lines stable. -repeat cbc in 1 week -f/u HIT serologies -hold SQH   #UTI asymptomatic and ucx growing enterococcus cloacae and VRE -asymptomatic and not septic, likely colonized, hold off on tx   #NAUSEA  #CONSTIPATION  Patient has baseline nausea even during prior hospitalization. Likely worsened by COVID infection. Ct showed no obstruction and no evidence of cholecystitis or other acute abnormalities. No abdominal pain or peritoneal signs. -f/u general surgery for chole drain   #NONTRAUMATIC ACUTE KIDNEY INJURY  Cr 1.37 from baseline ~1, likely from dehydration. Resolved after fluids. -daily chem7 Reason for Hospital Admission (Admitting Diagnosis):  COVID-19 disease, AKI
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Carbon dioxide increased, Computerised tomogram abdomen normal, Constipation, Cough
Clinical narrative: 81 Y female with hx of HTN, HLD, MDD, pulmonary HTN, bedbound status due to severe obesity and hip/knee arthritis, recent hospitalization 12/3-12/15/21 for acute cholecystitis s/p cholecystostomy on 12/4/21 c/b bacteremia, buttock wounds and R leg cellulitis, COVID-19 positive on 12/25/21, who presented with nausea and malaise. Remained non-hypoxic, received remesivir x3 days to prevent severe disease per ID recs. Was noted to be neutropenic fever likely due to COVID. Labs not suggestive of DIC. HIT labs pending, SQ heparin held. Urine cx grew enterococcus cloacae and VRE but was asymptomatic, likely colonized urine. Patient and family opted to bring patient home with home health PT, declined SNF. Patient safe to be off isolation now per current guidelines.  #CORONAVIRUS COVID-19 DISEASE Received first dose Moderna vaccine on 12/14/21. Symptom onset on ~12/17/21, COVID positive on 12/25/21. Last known fever on 12/29/21. Except for cough and malaise, no respiratory symptoms, satting well on room air. No oxygen requirement. CRP mildly elevated. Risk factors: obesity. Patient remained nonhypoxic. Was treated with remdesivir for 3 days (12/29-12/31) given she has risk factor (obesity) and for prevention to severe disease per ID recommendations    #NEUTROPENIC FEVER #LEUKOPENIA  #THROMBOCYTOPENIA, UNSPECIFIED  Neutropenia secondary to COVID. DIC labs negative. Patient was on SQ heparin at SNF and last hospitalization. 4T score for HIT is 2 points: low probability for HIT. Noted to have neutropenic fever on 12/31. Source of fever likely COVID. Blood cultures no growth. Dc'ed abx given likely from COVID. Cell lines stable. -repeat cbc in 1 week -f/u HIT serologies -hold SQH   #UTI asymptomatic and ucx growing enterococcus cloacae and VRE -asymptomatic and not septic, likely colonized, hold off on tx   #NAUSEA  #CONSTIPATION  Patient has baseline nausea even during prior hospitalization. Likely worsened by COVID infection. Ct showed no obstruction and no evidence of cholecystitis or other acute abnormalities. No abdominal pain or peritoneal signs. -f/u general surgery for chole drain   #NONTRAUMATIC ACUTE KIDNEY INJURY  Cr 1.37 from baseline ~1, likely from dehydration. Resolved after fluids. -daily chem7 Reason for Hospital Admission (Admitting Diagnosis):  COVID-19 disease, AKI
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Culture urine positive, Dehydration, Febrile neutropenia, Full blood count, Glycosylated haemoglobin
Clinical narrative: 81 Y female with hx of HTN, HLD, MDD, pulmonary HTN, bedbound status due to severe obesity and hip/knee arthritis, recent hospitalization 12/3-12/15/21 for acute cholecystitis s/p cholecystostomy on 12/4/21 c/b bacteremia, buttock wounds and R leg cellulitis, COVID-19 positive on 12/25/21, who presented with nausea and malaise. Remained non-hypoxic, received remesivir x3 days to prevent severe disease per ID recs. Was noted to be neutropenic fever likely due to COVID. Labs not suggestive of DIC. HIT labs pending, SQ heparin held. Urine cx grew enterococcus cloacae and VRE but was asymptomatic, likely colonized urine. Patient and family opted to bring patient home with home health PT, declined SNF. Patient safe to be off isolation now per current guidelines.  #CORONAVIRUS COVID-19 DISEASE Received first dose Moderna vaccine on 12/14/21. Symptom onset on ~12/17/21, COVID positive on 12/25/21. Last known fever on 12/29/21. Except for cough and malaise, no respiratory symptoms, satting well on room air. No oxygen requirement. CRP mildly elevated. Risk factors: obesity. Patient remained nonhypoxic. Was treated with remdesivir for 3 days (12/29-12/31) given she has risk factor (obesity) and for prevention to severe disease per ID recommendations    #NEUTROPENIC FEVER #LEUKOPENIA  #THROMBOCYTOPENIA, UNSPECIFIED  Neutropenia secondary to COVID. DIC labs negative. Patient was on SQ heparin at SNF and last hospitalization. 4T score for HIT is 2 points: low probability for HIT. Noted to have neutropenic fever on 12/31. Source of fever likely COVID. Blood cultures no growth. Dc'ed abx given likely from COVID. Cell lines stable. -repeat cbc in 1 week -f/u HIT serologies -hold SQH   #UTI asymptomatic and ucx growing enterococcus cloacae and VRE -asymptomatic and not septic, likely colonized, hold off on tx   #NAUSEA  #CONSTIPATION  Patient has baseline nausea even during prior hospitalization. Likely worsened by COVID infection. Ct showed no obstruction and no evidence of cholecystitis or other acute abnormalities. No abdominal pain or peritoneal signs. -f/u general surgery for chole drain   #NONTRAUMATIC ACUTE KIDNEY INJURY  Cr 1.37 from baseline ~1, likely from dehydration. Resolved after fluids. -daily chem7 Reason for Hospital Admission (Admitting Diagnosis):  COVID-19 disease, AKI
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Haematocrit normal, Haemoglobin normal, High density lipoprotein decreased, Leukopenia, Lymphocyte percentage
Clinical narrative: 81 Y female with hx of HTN, HLD, MDD, pulmonary HTN, bedbound status due to severe obesity and hip/knee arthritis, recent hospitalization 12/3-12/15/21 for acute cholecystitis s/p cholecystostomy on 12/4/21 c/b bacteremia, buttock wounds and R leg cellulitis, COVID-19 positive on 12/25/21, who presented with nausea and malaise. Remained non-hypoxic, received remesivir x3 days to prevent severe disease per ID recs. Was noted to be neutropenic fever likely due to COVID. Labs not suggestive of DIC. HIT labs pending, SQ heparin held. Urine cx grew enterococcus cloacae and VRE but was asymptomatic, likely colonized urine. Patient and family opted to bring patient home with home health PT, declined SNF. Patient safe to be off isolation now per current guidelines.  #CORONAVIRUS COVID-19 DISEASE Received first dose Moderna vaccine on 12/14/21. Symptom onset on ~12/17/21, COVID positive on 12/25/21. Last known fever on 12/29/21. Except for cough and malaise, no respiratory symptoms, satting well on room air. No oxygen requirement. CRP mildly elevated. Risk factors: obesity. Patient remained nonhypoxic. Was treated with remdesivir for 3 days (12/29-12/31) given she has risk factor (obesity) and for prevention to severe disease per ID recommendations    #NEUTROPENIC FEVER #LEUKOPENIA  #THROMBOCYTOPENIA, UNSPECIFIED  Neutropenia secondary to COVID. DIC labs negative. Patient was on SQ heparin at SNF and last hospitalization. 4T score for HIT is 2 points: low probability for HIT. Noted to have neutropenic fever on 12/31. Source of fever likely COVID. Blood cultures no growth. Dc'ed abx given likely from COVID. Cell lines stable. -repeat cbc in 1 week -f/u HIT serologies -hold SQH   #UTI asymptomatic and ucx growing enterococcus cloacae and VRE -asymptomatic and not septic, likely colonized, hold off on tx   #NAUSEA  #CONSTIPATION  Patient has baseline nausea even during prior hospitalization. Likely worsened by COVID infection. Ct showed no obstruction and no evidence of cholecystitis or other acute abnormalities. No abdominal pain or peritoneal signs. -f/u general surgery for chole drain   #NONTRAUMATIC ACUTE KIDNEY INJURY  Cr 1.37 from baseline ~1, likely from dehydration. Resolved after fluids. -daily chem7 Reason for Hospital Admission (Admitting Diagnosis):  COVID-19 disease, AKI
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Mean cell volume normal, Monocyte percentage, Nausea, Neutropenia
Clinical narrative: 81 Y female with hx of HTN, HLD, MDD, pulmonary HTN, bedbound status due to severe obesity and hip/knee arthritis, recent hospitalization 12/3-12/15/21 for acute cholecystitis s/p cholecystostomy on 12/4/21 c/b bacteremia, buttock wounds and R leg cellulitis, COVID-19 positive on 12/25/21, who presented with nausea and malaise. Remained non-hypoxic, received remesivir x3 days to prevent severe disease per ID recs. Was noted to be neutropenic fever likely due to COVID. Labs not suggestive of DIC. HIT labs pending, SQ heparin held. Urine cx grew enterococcus cloacae and VRE but was asymptomatic, likely colonized urine. Patient and family opted to bring patient home with home health PT, declined SNF. Patient safe to be off isolation now per current guidelines.  #CORONAVIRUS COVID-19 DISEASE Received first dose Moderna vaccine on 12/14/21. Symptom onset on ~12/17/21, COVID positive on 12/25/21. Last known fever on 12/29/21. Except for cough and malaise, no respiratory symptoms, satting well on room air. No oxygen requirement. CRP mildly elevated. Risk factors: obesity. Patient remained nonhypoxic. Was treated with remdesivir for 3 days (12/29-12/31) given she has risk factor (obesity) and for prevention to severe disease per ID recommendations    #NEUTROPENIC FEVER #LEUKOPENIA  #THROMBOCYTOPENIA, UNSPECIFIED  Neutropenia secondary to COVID. DIC labs negative. Patient was on SQ heparin at SNF and last hospitalization. 4T score for HIT is 2 points: low probability for HIT. Noted to have neutropenic fever on 12/31. Source of fever likely COVID. Blood cultures no growth. Dc'ed abx given likely from COVID. Cell lines stable. -repeat cbc in 1 week -f/u HIT serologies -hold SQH   #UTI asymptomatic and ucx growing enterococcus cloacae and VRE -asymptomatic and not septic, likely colonized, hold off on tx   #NAUSEA  #CONSTIPATION  Patient has baseline nausea even during prior hospitalization. Likely worsened by COVID infection. Ct showed no obstruction and no evidence of cholecystitis or other acute abnormalities. No abdominal pain or peritoneal signs. -f/u general surgery for chole drain   #NONTRAUMATIC ACUTE KIDNEY INJURY  Cr 1.37 from baseline ~1, likely from dehydration. Resolved after fluids. -daily chem7 Reason for Hospital Admission (Admitting Diagnosis):  COVID-19 disease, AKI
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Neutrophil percentage, Nitrite urine absent, Platelet count decreased, Protein urine present, Pyrexia
Clinical narrative: 81 Y female with hx of HTN, HLD, MDD, pulmonary HTN, bedbound status due to severe obesity and hip/knee arthritis, recent hospitalization 12/3-12/15/21 for acute cholecystitis s/p cholecystostomy on 12/4/21 c/b bacteremia, buttock wounds and R leg cellulitis, COVID-19 positive on 12/25/21, who presented with nausea and malaise. Remained non-hypoxic, received remesivir x3 days to prevent severe disease per ID recs. Was noted to be neutropenic fever likely due to COVID. Labs not suggestive of DIC. HIT labs pending, SQ heparin held. Urine cx grew enterococcus cloacae and VRE but was asymptomatic, likely colonized urine. Patient and family opted to bring patient home with home health PT, declined SNF. Patient safe to be off isolation now per current guidelines.  #CORONAVIRUS COVID-19 DISEASE Received first dose Moderna vaccine on 12/14/21. Symptom onset on ~12/17/21, COVID positive on 12/25/21. Last known fever on 12/29/21. Except for cough and malaise, no respiratory symptoms, satting well on room air. No oxygen requirement. CRP mildly elevated. Risk factors: obesity. Patient remained nonhypoxic. Was treated with remdesivir for 3 days (12/29-12/31) given she has risk factor (obesity) and for prevention to severe disease per ID recommendations    #NEUTROPENIC FEVER #LEUKOPENIA  #THROMBOCYTOPENIA, UNSPECIFIED  Neutropenia secondary to COVID. DIC labs negative. Patient was on SQ heparin at SNF and last hospitalization. 4T score for HIT is 2 points: low probability for HIT. Noted to have neutropenic fever on 12/31. Source of fever likely COVID. Blood cultures no growth. Dc'ed abx given likely from COVID. Cell lines stable. -repeat cbc in 1 week -f/u HIT serologies -hold SQH   #UTI asymptomatic and ucx growing enterococcus cloacae and VRE -asymptomatic and not septic, likely colonized, hold off on tx   #NAUSEA  #CONSTIPATION  Patient has baseline nausea even during prior hospitalization. Likely worsened by COVID infection. Ct showed no obstruction and no evidence of cholecystitis or other acute abnormalities. No abdominal pain or peritoneal signs. -f/u general surgery for chole drain   #NONTRAUMATIC ACUTE KIDNEY INJURY  Cr 1.37 from baseline ~1, likely from dehydration. Resolved after fluids. -daily chem7 Reason for Hospital Admission (Admitting Diagnosis):  COVID-19 disease, AKI
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Red blood cells urine, SARS-CoV-2 test positive, Thrombocytopenia, Troponin, Urinary tract infection
Clinical narrative: 81 Y female with hx of HTN, HLD, MDD, pulmonary HTN, bedbound status due to severe obesity and hip/knee arthritis, recent hospitalization 12/3-12/15/21 for acute cholecystitis s/p cholecystostomy on 12/4/21 c/b bacteremia, buttock wounds and R leg cellulitis, COVID-19 positive on 12/25/21, who presented with nausea and malaise. Remained non-hypoxic, received remesivir x3 days to prevent severe disease per ID recs. Was noted to be neutropenic fever likely due to COVID. Labs not suggestive of DIC. HIT labs pending, SQ heparin held. Urine cx grew enterococcus cloacae and VRE but was asymptomatic, likely colonized urine. Patient and family opted to bring patient home with home health PT, declined SNF. Patient safe to be off isolation now per current guidelines.  #CORONAVIRUS COVID-19 DISEASE Received first dose Moderna vaccine on 12/14/21. Symptom onset on ~12/17/21, COVID positive on 12/25/21. Last known fever on 12/29/21. Except for cough and malaise, no respiratory symptoms, satting well on room air. No oxygen requirement. CRP mildly elevated. Risk factors: obesity. Patient remained nonhypoxic. Was treated with remdesivir for 3 days (12/29-12/31) given she has risk factor (obesity) and for prevention to severe disease per ID recommendations    #NEUTROPENIC FEVER #LEUKOPENIA  #THROMBOCYTOPENIA, UNSPECIFIED  Neutropenia secondary to COVID. DIC labs negative. Patient was on SQ heparin at SNF and last hospitalization. 4T score for HIT is 2 points: low probability for HIT. Noted to have neutropenic fever on 12/31. Source of fever likely COVID. Blood cultures no growth. Dc'ed abx given likely from COVID. Cell lines stable. -repeat cbc in 1 week -f/u HIT serologies -hold SQH   #UTI asymptomatic and ucx growing enterococcus cloacae and VRE -asymptomatic and not septic, likely colonized, hold off on tx   #NAUSEA  #CONSTIPATION  Patient has baseline nausea even during prior hospitalization. Likely worsened by COVID infection. Ct showed no obstruction and no evidence of cholecystitis or other acute abnormalities. No abdominal pain or peritoneal signs. -f/u general surgery for chole drain   #NONTRAUMATIC ACUTE KIDNEY INJURY  Cr 1.37 from baseline ~1, likely from dehydration. Resolved after fluids. -daily chem7 Reason for Hospital Admission (Admitting Diagnosis):  COVID-19 disease, AKI
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Urine ketone body absent, Urine leukocyte esterase, Urobilinogen urine decreased, White blood cell count decreased, White blood cells urine
Clinical narrative: 81 Y female with hx of HTN, HLD, MDD, pulmonary HTN, bedbound status due to severe obesity and hip/knee arthritis, recent hospitalization 12/3-12/15/21 for acute cholecystitis s/p cholecystostomy on 12/4/21 c/b bacteremia, buttock wounds and R leg cellulitis, COVID-19 positive on 12/25/21, who presented with nausea and malaise. Remained non-hypoxic, received remesivir x3 days to prevent severe disease per ID recs. Was noted to be neutropenic fever likely due to COVID. Labs not suggestive of DIC. HIT labs pending, SQ heparin held. Urine cx grew enterococcus cloacae and VRE but was asymptomatic, likely colonized urine. Patient and family opted to bring patient home with home health PT, declined SNF. Patient safe to be off isolation now per current guidelines.  #CORONAVIRUS COVID-19 DISEASE Received first dose Moderna vaccine on 12/14/21. Symptom onset on ~12/17/21, COVID positive on 12/25/21. Last known fever on 12/29/21. Except for cough and malaise, no respiratory symptoms, satting well on room air. No oxygen requirement. CRP mildly elevated. Risk factors: obesity. Patient remained nonhypoxic. Was treated with remdesivir for 3 days (12/29-12/31) given she has risk factor (obesity) and for prevention to severe disease per ID recommendations    #NEUTROPENIC FEVER #LEUKOPENIA  #THROMBOCYTOPENIA, UNSPECIFIED  Neutropenia secondary to COVID. DIC labs negative. Patient was on SQ heparin at SNF and last hospitalization. 4T score for HIT is 2 points: low probability for HIT. Noted to have neutropenic fever on 12/31. Source of fever likely COVID. Blood cultures no growth. Dc'ed abx given likely from COVID. Cell lines stable. -repeat cbc in 1 week -f/u HIT serologies -hold SQH   #UTI asymptomatic and ucx growing enterococcus cloacae and VRE -asymptomatic and not septic, likely colonized, hold off on tx   #NAUSEA  #CONSTIPATION  Patient has baseline nausea even during prior hospitalization. Likely worsened by COVID infection. Ct showed no obstruction and no evidence of cholecystitis or other acute abnormalities. No abdominal pain or peritoneal signs. -f/u general surgery for chole drain   #NONTRAUMATIC ACUTE KIDNEY INJURY  Cr 1.37 from baseline ~1, likely from dehydration. Resolved after fluids. -daily chem7 Reason for Hospital Admission (Admitting Diagnosis):  COVID-19 disease, AKI
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: pH urine normal
Clinical narrative: 81 Y female with hx of HTN, HLD, MDD, pulmonary HTN, bedbound status due to severe obesity and hip/knee arthritis, recent hospitalization 12/3-12/15/21 for acute cholecystitis s/p cholecystostomy on 12/4/21 c/b bacteremia, buttock wounds and R leg cellulitis, COVID-19 positive on 12/25/21, who presented with nausea and malaise. Remained non-hypoxic, received remesivir x3 days to prevent severe disease per ID recs. Was noted to be neutropenic fever likely due to COVID. Labs not suggestive of DIC. HIT labs pending, SQ heparin held. Urine cx grew enterococcus cloacae and VRE but was asymptomatic, likely colonized urine. Patient and family opted to bring patient home with home health PT, declined SNF. Patient safe to be off isolation now per current guidelines.  #CORONAVIRUS COVID-19 DISEASE Received first dose Moderna vaccine on 12/14/21. Symptom onset on ~12/17/21, COVID positive on 12/25/21. Last known fever on 12/29/21. Except for cough and malaise, no respiratory symptoms, satting well on room air. No oxygen requirement. CRP mildly elevated. Risk factors: obesity. Patient remained nonhypoxic. Was treated with remdesivir for 3 days (12/29-12/31) given she has risk factor (obesity) and for prevention to severe disease per ID recommendations    #NEUTROPENIC FEVER #LEUKOPENIA  #THROMBOCYTOPENIA, UNSPECIFIED  Neutropenia secondary to COVID. DIC labs negative. Patient was on SQ heparin at SNF and last hospitalization. 4T score for HIT is 2 points: low probability for HIT. Noted to have neutropenic fever on 12/31. Source of fever likely COVID. Blood cultures no growth. Dc'ed abx given likely from COVID. Cell lines stable. -repeat cbc in 1 week -f/u HIT serologies -hold SQH   #UTI asymptomatic and ucx growing enterococcus cloacae and VRE -asymptomatic and not septic, likely colonized, hold off on tx   #NAUSEA  #CONSTIPATION  Patient has baseline nausea even during prior hospitalization. Likely worsened by COVID infection. Ct showed no obstruction and no evidence of cholecystitis or other acute abnormalities. No abdominal pain or peritoneal signs. -f/u general surgery for chole drain   #NONTRAUMATIC ACUTE KIDNEY INJURY  Cr 1.37 from baseline ~1, likely from dehydration. Resolved after fluids. -daily chem7 Reason for Hospital Admission (Admitting Diagnosis):  COVID-19 disease, AKI
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Dysphagia, Feeling hot
Clinical narrative: pt complained of having trouble swallowing after approx 10 minutes from administration as well as feeling warm in the torso area
Age: 6.0
Sex: F
Vaccine: COVID19
Symptoms: Immunisation, Incorrect dose administered
Clinical narrative: 1/19/22, I went to administer vaccine to patient while sitting on mothers lap. Upon administration of the vaccine the child pulled her arm back and the vaccine went down her arm instead of IM. She was re-administered the vaccine and no further issues.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Chest X-ray, Chest discomfort, Dyspnoea, Electrocardiogram, Troponin I
Clinical narrative: Patient reported chest pressure/tightness to center of chest with difficulties taking a deep breath.  Per pt, completed 30 mins of observation after receiving Pfizer booster and left the building to go to Bank. Developed chest tightness there and drove back to building. Vitals obtained and patient evaluated by MD.
Age: 41.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Pruritus, Rash, Urticaria
Clinical narrative: Urticaria: Rash/hives 10 days after shot. Very itchy especially on palm of hands and scalp. Urgent care doctor put me on prednisone and Benadryl but the allergist changed it to Montelukast 10mg 1 tablet at night, fexofenadine 1180 mg 1 tablet a day, carbinoxamine 4mg 1 tablet at night, and famotidine 40mg 2 times a day.
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Large axillary lymhnodes, both left and right sides. Still large 10 months later
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Administered after the end of the date of use.
Age: 14.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Feeling of body temperature change, Headache, Nausea, Pyrexia
Clinical narrative: Nauseous hot cold light headed headache headache low grade fever
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Decreased appetite, Fatigue, Headache, Nausea
Clinical narrative: All over body rash, head ache, severe body aches, nauseated, loss of appetite, weak, exhaustion,
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Rash
Clinical narrative: All over body rash, head ache, severe body aches, nauseated, loss of appetite, weak, exhaustion,
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Mobility decreased, Sensory loss, Spinal pain, Urinary incontinence
Clinical narrative: Member received Moderna COVID-19 booster of 0.25ml into his L arm on 14 Jan 2022 at approx. 1100. Patient felt no immediate effects but reports at approx midnight the same day he woke up from urinary incontinence with no mobility of legs for approx. 2 hours before being transported to the ER. Upon ER evaluation started to regain some sensation in his legs w/ sharp pain in the center of his lower spine. Patient was released from ER to primary care provider, currently undergoing treatment.
Age: 37.0
Sex: F
Vaccine: UNK
Symptoms: Chest pain, Cough, Dyspnoea, Headache, Myalgia
Clinical narrative: headaches, muscle pain, problems breathing, cough, nausea, chest pain. vision problems.
Age: 37.0
Sex: F
Vaccine: UNK
Symptoms: Nausea, Visual impairment
Clinical narrative: headaches, muscle pain, problems breathing, cough, nausea, chest pain. vision problems.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Developed hives that re-appear in different parts of the body within 24 hours
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: Hospitalization
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Administered after the end of the date of use.
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Biopsy, Blood test, Complement factor C3 decreased, Complement factor C4 decreased, Cyanosis
Clinical narrative: After receiving Covid vaccinations:  Biopsy proven Small Fiber Neuropathy, chronic pain/myalgia/paresthesia/fatigue and Tinnitus, muscle fasciculations,  Symptomatic Ventricular Bi and Trigeminy, Dry eyes, sharp facial and ear pain, blue feet
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dry eye, Ear pain, Echocardiogram, Electrocardiogram, Electrocardiogram ambulatory
Clinical narrative: After receiving Covid vaccinations:  Biopsy proven Small Fiber Neuropathy, chronic pain/myalgia/paresthesia/fatigue and Tinnitus, muscle fasciculations,  Symptomatic Ventricular Bi and Trigeminy, Dry eyes, sharp facial and ear pain, blue feet
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Electromyogram, Exercise electrocardiogram, Facial pain, Fatigue, Feeling abnormal
Clinical narrative: After receiving Covid vaccinations:  Biopsy proven Small Fiber Neuropathy, chronic pain/myalgia/paresthesia/fatigue and Tinnitus, muscle fasciculations,  Symptomatic Ventricular Bi and Trigeminy, Dry eyes, sharp facial and ear pain, blue feet
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Lumbar puncture, Magnetic resonance imaging head, Magnetic resonance imaging thoracic, Muscle contractions involuntary, Muscle twitching
Clinical narrative: After receiving Covid vaccinations:  Biopsy proven Small Fiber Neuropathy, chronic pain/myalgia/paresthesia/fatigue and Tinnitus, muscle fasciculations,  Symptomatic Ventricular Bi and Trigeminy, Dry eyes, sharp facial and ear pain, blue feet
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Myalgia, Paraesthesia, Scan with contrast, Small fibre neuropathy, Tinnitus
Clinical narrative: After receiving Covid vaccinations:  Biopsy proven Small Fiber Neuropathy, chronic pain/myalgia/paresthesia/fatigue and Tinnitus, muscle fasciculations,  Symptomatic Ventricular Bi and Trigeminy, Dry eyes, sharp facial and ear pain, blue feet
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Ventricular extrasystoles
Clinical narrative: After receiving Covid vaccinations:  Biopsy proven Small Fiber Neuropathy, chronic pain/myalgia/paresthesia/fatigue and Tinnitus, muscle fasciculations,  Symptomatic Ventricular Bi and Trigeminy, Dry eyes, sharp facial and ear pain, blue feet
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Condition aggravated, Energy increased, Fatigue
Clinical narrative: 02/26/2021, the day after the vaccination, I had considerable soreness in my left shoulder, at the point of injection. I had some fatigue and a little bit of a headache, and my energy level kept up and down for the day. The soreness in the area near the injection site got worse for the next several of days. After approximately 5 days, I called the doctor because  I could not move my arm at that point, it was like I had a torn rotator cuff. They told me to monitor it and it eventually started to abate after 10 to 14 days.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Injected limb mobility decreased, Injection site pain, Mobility decreased
Clinical narrative: 02/26/2021, the day after the vaccination, I had considerable soreness in my left shoulder, at the point of injection. I had some fatigue and a little bit of a headache, and my energy level kept up and down for the day. The soreness in the area near the injection site got worse for the next several of days. After approximately 5 days, I called the doctor because  I could not move my arm at that point, it was like I had a torn rotator cuff. They told me to monitor it and it eventually started to abate after 10 to 14 days.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: Hospitalization
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Disorientation, Dizziness, Flushing, Hypotension
Clinical narrative: Patient experienced abdominal discomfort. Patient had several episodes of vomiting.  Facial coloration flushed. Tingling sensation in fingers.  Patient was light headed/disoriented. Low blood pressure.
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Vomiting
Clinical narrative: Patient experienced abdominal discomfort. Patient had several episodes of vomiting.  Facial coloration flushed. Tingling sensation in fingers.  Patient was light headed/disoriented. Low blood pressure.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Administered dose after the limit to use the vaccine.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: 2nd dose given 8-30-2021 - 3rd dose given too early
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Ear discomfort, Pain in extremity, Tremor
Clinical narrative: Patient felt pain in arm, ears closing up, shaking, felt faint
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: Hospitalization
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: This individual came to a vaccine clinic we were holding at a local center and asked for a booster dose.  He had one dose of Moderna vaccine and needed the 2nd dose given. The person who was helping me in collecting patient information and obtaining consent for treatment, misunderstood vaccine information in database.  She handed me the consent form and wrote on the form that the patient needed a booster. I gave the individual   a booster and when I got back to the clinic, and during documentation, noticed that patient only had one dose of Moderna and really needed dose #2. We contacted the center where he was staying but he had left the center and did not have any phone numbers for follow up.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Blood test, COVID-19, Pain in extremity, SARS-CoV-2 test positive
Clinical narrative: Tested positive for covid 19 ,  Consistent pain and foot and bilateral hands
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Administered after administration deadline.
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Facial discomfort, Lip swelling, Mechanical urticaria, Pruritus, Rash macular
Clinical narrative: Chronic urticaria started 8-10 days after the booster shot (3rd dose of Moderna). I started getting red splotches and itching over my whole body. I also had spontaneous face swelling and a fat lip while just sitting at my desk working. Hives and itching persisted for 3-5 days until I saw a doctor.  He said they were hive-like symptoms and maybe dermatographia. I started taking cetirizine 10mg daily and the itching went away. However the random red splotches (hives) still show up randomly even a month later. Face still feels funny at least once a day as well. I tried stop taking cetirizine for a day and the itching comes back. After doing some research online I found some medical journal entries that are almost identical to mine. It is 100% a result of the Moderna booster shot. Several other patients had the exact same symptoms from the COVID-19 vaccine. I have never had any of these symptoms in my life before this.  Even with the itching gone, I still have dermatographia and now the chronic urticaria.
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Swelling face, Urticaria, Urticaria chronic
Clinical narrative: Chronic urticaria started 8-10 days after the booster shot (3rd dose of Moderna). I started getting red splotches and itching over my whole body. I also had spontaneous face swelling and a fat lip while just sitting at my desk working. Hives and itching persisted for 3-5 days until I saw a doctor.  He said they were hive-like symptoms and maybe dermatographia. I started taking cetirizine 10mg daily and the itching went away. However the random red splotches (hives) still show up randomly even a month later. Face still feels funny at least once a day as well. I tried stop taking cetirizine for a day and the itching comes back. After doing some research online I found some medical journal entries that are almost identical to mine. It is 100% a result of the Moderna booster shot. Several other patients had the exact same symptoms from the COVID-19 vaccine. I have never had any of these symptoms in my life before this.  Even with the itching gone, I still have dermatographia and now the chronic urticaria.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Vaginal ulceration, Vulvovaginal discomfort, Vulvovaginal pruritus
Clinical narrative: Vaginal ulcers in non sexually active patient. Slight irritation and itchyness occured in the vagina two days after the vaccine was administered. Over the course of two days, three painful ulcers formed around the vagina. Ulcers lasted five days and healed after Zovirax cream was perscribed and used.
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Administered dose after the limit to use the vaccine.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site haemorrhage
Clinical narrative: EXCESS BLEEDING WHEN NEEDLE REMOVED FROM ARM
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Administered dose after the limit to use the vaccine.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Throat irritation, Urticaria
Clinical narrative: Hives to chest, tingling to hands, itchy to throat
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Lymphadenopathy, Mass, Rash
Clinical narrative: Patient had Rash and LUMP ON LEFT CLAVICAL AREA, She was diagnosed with LYMPHADENOPATHY. She noted the next morning of vaccine, had some burning sensation. She has to follow up the doctor in 3 to 4 days.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Wrong product administered
Clinical narrative: Patient had received monoclonal antibodies (bamlanivimab) 09JAN22.  Patient then received a Moderna booster 20JAN22.  Patient unknowingly filled the form incorrectly prior to receiving Moderna.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Pain in extremity, Paraesthesia, Peripheral swelling
Clinical narrative: . Patient stated that she is still having swelling, pain, numbness, and tingling in the arm that she received her first Moderna Covid Vaccine.
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Administered dose after the limit to use the vaccine.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Dyspnoea, Myasthenia gravis, Vaccination site reaction
Clinical narrative: Exacerbation of Myasthenia Gravis Symptoms including insufficient breathing requiring the use of my Ventilator.  "Covid Arm" 3 days after injection
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Lymphadenopathy, Paraesthesia
Clinical narrative: swollen lymph nodes in armpits, tingling in fingers, fatigue
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Biopsy colon, Blood test, Colon adenoma, Colonoscopy, Constipation
Clinical narrative: Changes in GI tract. Frequent nausea, vomiting, changes in bowel habits (constantly constipated or having diarrhea).  Usually sick for 3-4 days at a time, every few weeks. Starts with nausea, then vomiting, and diarrhea. In between these episodes, I am usually constipated.  Events started roughly 6 hours after receiving the vaccine. Prior to this, no GI issues.